{"id":"W3142959462","doi":"10.1016/s2352-3018(20)30340-4","title":"Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study","year":2021,"lang":"en","type":"article","venue":"The Lancet HIV","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"ca_institutions":"GlaxoSmithKline (Canada); St. Michael's Hospital","funders":"Janssen Research and Development; Barts Charity; ViiV Healthcare; Janssen Pharmaceuticals; Gilead Sciences","keywords":"Rilpivirine; Medicine; Dolutegravir; Abacavir; Emtricitabine; Regimen; Lamivudine; Internal medicine; Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy; Virology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007364568,0.0001668103,0.0006149727,0.00005861624,0.0001830167,0.00004591779,0.0002472256,0.00003425751,0.00008169465],"category_scores_gemma":[0.0006389348,0.00008192363,0.0001090753,0.000444171,0.00009283564,0.0001007756,0.0001259042,0.0002011614,0.00001512665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001659337,"about_ca_system_score_gemma":0.0002919124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001163648,"about_ca_topic_score_gemma":0.008420059,"domain_scores_codex":[0.9983533,0.0003338737,0.0004250016,0.0002958938,0.0002591507,0.0003327893],"domain_scores_gemma":[0.9984842,0.0003384646,0.0001579285,0.0007387677,0.0001988506,0.00008179126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6357819,0.05099307,0.07202008,0.001327688,0.003175181,0.0008741915,0.0276232,0.000409314,0.004926799,0.0002405601,0.08904318,0.1135848],"study_design_scores_gemma":[0.9149059,0.02496269,0.01907312,0.002314785,0.0004205413,0.0001132923,0.003932332,0.003827118,0.01076195,0.00005203023,0.01937423,0.000262002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810359,0.0002061089,0.0003772577,0.005830973,0.00005791316,0.004375163,0.0002703375,0.00002607379,0.007820302],"genre_scores_gemma":[0.967931,0.0001246267,0.0002212809,0.00006896614,0.0002586888,0.0007067743,0.0001268835,0.00002305693,0.03053869],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.279124,"threshold_uncertainty_score":0.4698591,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07966455498937293,"score_gpt":0.393228581801075,"score_spread":0.313564026811702,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}